Document is current

Any future updates will be listed below

Impact of Switching from Twice-Daily Basal Insulin to Once-Daily Insulin Glargine 300 U/mL in People with Type 1 Diabetes on Basal–Bolus Insulin: Phase 4 OPTIMIZE Study

Crossref DOI link: https://doi.org/10.1007/s13300-019-00749-1

Published Online: 2020-01-10

Published Print: 2020-02

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark